Nathalie Grardel

Lille, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications

Age-adapted chemotherapy and MRD-oriented transplant for Ph-negative acute lymphoblastic leukemia: the GRAALL-2014 trial.

Age-adapted chemotherapy and MRD-oriented transplant for Ph-negative acute lymphoblastic leukemia: the GRAALL-2014 trial.

Journal: Blood
Published: April 15, 2025

Age-adapted chemotherapy and MRD-oriented transplant for Ph-negative acute lymphoblastic leukemia: the GRAALL-2014 trial.

Age-adapted chemotherapy and MRD-oriented transplant for Ph-negative acute lymphoblastic leukemia: the GRAALL-2014 trial.

Journal: Blood
Published: April 15, 2025

Development and Validation of the FIP Score for the Screening of FIP1L1::PDGFRA-Associated Hypereosinophilic Syndrome.

Development and Validation of the FIP Score for the Screening of FIP1L1::PDGFRA-Associated Hypereosinophilic Syndrome.

Journal: The journal of allergy and clinical immunology. In practice
Published: March 11, 2025

Oncogenomic profiling in infant-toddler T-ALL identifies NKX2 family genes as drivers linked to favorable outcomes.

Oncogenomic profiling in infant-toddler T-ALL identifies NKX2 family genes as drivers linked to favorable outcomes.

Journal: HemaSphere
Published: February 26, 2025

Results of the prospective EORTC Children Leukemia Group study 58081 in precursor B- and T-cell acute lymphoblastic leukemia.

Results of the prospective EORTC Children Leukemia Group study 58081 in precursor B- and T-cell acute lymphoblastic leukemia.

Journal: HemaSphere
Published: March 06, 2024

Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes: A nationwide CEREO study.

Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes: A nationwide CEREO study.

Journal: American journal of hematology
Published: March 04, 2024

NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients.

NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients.

Journal: Blood
Published: January 10, 2024

Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study.

Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study.

Journal: Blood
Published: June 13, 2023

The KMT2A recombinome of acute leukemias in 2023.

The KMT2A recombinome of acute leukemias in 2023.

Journal: Leukemia
Published: February 08, 2023

The prognostic value of IKZF1plus in B-cell progenitor acute lymphoblastic leukemia: Results from the EORTC 58951 trial.

The prognostic value of IKZF1plus in B-cell progenitor acute lymphoblastic leukemia: Results from the EORTC 58951 trial.

Journal: Pediatric blood & cancer
Published: December 06, 2022

Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis.

Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis.

Journal: Blood cancer discovery
Published: September 21, 2022

Prognostic value and oncogenic landscape of TP53 alterations in adult and pediatric T-ALL.

Prognostic value and oncogenic landscape of TP53 alterations in adult and pediatric T-ALL.

Journal: Blood
Published: July 13, 2022
Showing 1-12 of 49

Last Updated: 09/26/2026